Levosalbutamol Hydrochloride (1.25mg) & Budesonide (0.5mg) Inhalation Suspension: Uses, Benefits, Dosage, Side Effects & Precautions

 Levosalbutamol Hydrochloride (1.25mg) and (0.5mg) Budesonide Inhalation Suspension, marketed under the brand name R.S. BUDEPRESS LEVO by Steris Healthcare, is a combination inhalation formulation containing a bronchodilator and an inhaled corticosteroid. It is designed for administration through a suitable nebulisation system and may be prescribed for selected obstructive airway conditions, depending on the patient's clinical assessment.

The two components provide complementary actions. Levosalbutamol hydrochloride 1.25 mg is a short-acting beta-2 agonist that helps relax airway smooth muscle, while budesonide 0.5 mg is a corticosteroid that reduces inflammation in the airways. Steris Healthcare lists R.S. BUDEPRESS LEVO with this composition and a 50-respule pack.

Because respiratory medicines can differ in strength, delivery method, and approved uses, R.S. BUDEPRESS LEVO should be used only according to the product information and healthcare professional's instructions.

Why it's important

Respiratory conditions can involve both airway narrowing and inflammation. Bronchospasm can make it difficult for air to move through the airways, while inflammation can contribute to swelling, mucus production, coughing, wheezing, and recurrent breathing symptoms.

The combination of levosalbutamol and budesonide addresses these two components through different mechanisms. Levosalbutamol acts on beta-2 receptors in airway smooth muscle to promote bronchodilation, while budesonide works locally to reduce inflammatory activity.

This dual-action approach can be useful when a healthcare professional determines that both bronchodilation and corticosteroid treatment are appropriate. It is important, however, not to assume that every combination nebuliser is suitable for every asthma or COPD episode.

Key Benefits of Levosalbutamol Hydrochloride (1.25mg) and (0.5mg) Budesonide Inhalation Suspension

The combination may provide respiratory benefits through complementary bronchodilator and anti-inflammatory activity.

What are the benefits of Levosalbutamol Hydrochloride (1.25mg) and (0.5mg) Budesonide Inhalation Suspension?

  • Helps relax constricted airway muscles through levosalbutamol.

  • Helps reduce airway inflammation through budesonide.

  • May support easier airflow in patients with reversible airway obstruction.

  • May help manage symptoms such as wheezing, coughing, and breathing difficulty when prescribed appropriately.

  • Provides two complementary respiratory actions in one inhalation formulation.

  • Nebulised administration may be useful for patients who have difficulty using certain inhaler devices.

  • Can form part of an individualized respiratory treatment plan under medical supervision.

The expected benefit varies according to the underlying respiratory condition, severity, age, treatment history, and individual response.

Side effects of Levosalbutamol Hydrochloride (1.25mg) and (0.5mg) Budesonide Inhalation Suspension

Like other respiratory medicines, this combination may cause side effects in some patients. Levosalbutamol may cause tremor, nervousness, headache, muscle cramps, or a sensation of increased heartbeat in some individuals.

Budesonide, as an inhaled corticosteroid, may cause throat irritation, cough, hoarseness, dry mouth, or oral fungal infection such as thrush. Rinsing the mouth with water and spitting it out after administration can help reduce corticosteroid residue in the mouth.

If side effects are persistent, severe, or unusual, consult a healthcare professional rather than changing the dose independently.

Serious Side Effects Of Levosalbutamol Hydrochloride (1.25mg) and (0.5mg) Budesonide Inhalation Suspension

Serious reactions are uncommon but require prompt medical attention. Seek urgent help if symptoms such as swelling of the face, lips, tongue, or throat, severe rash, fainting, or significant difficulty breathing suggest a serious allergic reaction.

Sudden worsening of breathing immediately after inhalation may indicate paradoxical bronchospasm and requires immediate medical assessment.

Levosalbutamol may affect heart rate or rhythm in susceptible individuals. Patients with cardiovascular disease, hypertension, arrhythmias, thyroid disorders, diabetes, or low potassium should inform their healthcare professional before treatment.

Available Substitute For Levosalbutamol Hydrochloride (1.25mg) and (0.5mg) Budesonide Inhalation Suspension

If R.S. BUDEPRESS LEVO is unavailable, a substitute should not be selected simply because it contains a similar combination. Alternative respiratory products may contain different strengths, active ingredients, preservatives, or delivery systems.

A doctor or pharmacist can recommend an appropriate alternative based on the patient's diagnosis and prescribed dose. Do not replace the product or change from a nebuliser formulation to another inhalation device without professional guidance.

Dosage Guidelines For Levosalbutamol Hydrochloride (1.25mg) and (0.5mg) Budesonide Inhalation Suspension

Use R.S. BUDEPRESS LEVO exactly as prescribed by your healthcare professional. The appropriate dose and frequency depend on the patient's age, diagnosis, symptom severity, treatment history, and response.

The product should be administered through an appropriate nebuliser according to the manufacturer's instructions. Do not swallow the respule contents, inject them, or use them through an unintended route.

Because budesonide nebuliser formulations have specific device requirements, the prescribed product should be administered using the nebulisation system recommended for that formulation. Official budesonide prescribing information specifies appropriate jet-nebuliser administration and states that ultrasonic nebulisers are not recommended for those formulations.

Do not increase the number of respules or frequency of treatment without medical advice.

Precautions & Warnings

Before using R.S. BUDEPRESS LEVO, inform your healthcare professional about allergies to levosalbutamol, budesonide, or any formulation ingredient.

Tell your doctor if you have heart disease, high blood pressure, irregular heartbeat, diabetes, thyroid problems, low potassium, seizures, liver disease, glaucoma, cataracts, tuberculosis, or other significant medical conditions.

Inform your healthcare professional about all medicines you take, especially other bronchodilators, corticosteroids, beta-blockers, diuretics, medicines affecting heart rhythm, and other respiratory medicines.

Patients receiving long-term corticosteroid treatment may require appropriate monitoring. Children receiving prolonged corticosteroid therapy may also require monitoring of growth and general health.

If breathing suddenly becomes severe or rapidly worsens, follow the emergency treatment plan provided by your healthcare professional and seek urgent medical attention.

Using Levosalbutamol Hydrochloride (1.25mg) and (0.5mg) Budesonide Inhalation Suspension

Correct nebuliser technique is important for effective delivery. Use the prescribed respule with a compatible nebuliser and follow the device manufacturer's instructions.

Open the single-dose container when ready for administration and place the prescribed contents into the nebuliser chamber. Use the mouthpiece or appropriate face mask as directed.

Budesonide-containing nebuliser formulations should not be mixed with other nebulised medicines unless compatibility has been specifically confirmed. Official prescribing information for budesonide inhalation suspension recommends separate administration because mixing has not been adequately assessed.

After treatment, rinse your mouth with water and spit it out. If a face mask is used, washing the face afterward can help remove medicine deposited on the skin. Clean the nebuliser equipment according to the manufacturer's instructions after each use.

Mechanism of Action of Levosalbutamol Hydrochloride (1.25mg) and (0.5mg) Budesonide Inhalation Suspension

Levosalbutamol hydrochloride is a selective beta-2 adrenergic receptor agonist. It stimulates beta-2 receptors in airway smooth muscle, promoting relaxation of the muscles surrounding the airways. This bronchodilator effect helps widen the air passages and improve airflow.

Budesonide is a synthetic corticosteroid with anti-inflammatory activity. After inhalation, it acts on glucocorticoid receptors in airway tissues and influences inflammatory processes. This reduces the activity of inflammatory mediators and can help decrease airway swelling and other inflammatory changes.

Together, the two components provide complementary effects: levosalbutamol primarily addresses airway smooth-muscle constriction, while budesonide addresses the inflammatory component of respiratory disease.

Transactional Information – Buy Levosalbutamol Hydrochloride (1.25mg) and (0.5mg) Budesonide Inhalation Suspension Online in India

If you are looking to buy Levosalbutamol Hydrochloride (1.25mg) and (0.5mg) Budesonide Inhalation Suspension online in India, R.S. BUDEPRESS LEVO from Steris Healthcare can be checked for current product availability and ordering information. Steris Healthcare's online listing identifies the product as a prescription item and lists a 50-respule package.

Before purchasing, verify the brand name, composition, strength, dosage form, pack size, manufacturer/marketer, batch number, expiry date, storage conditions, and applicable prescription requirements. Purchase respiratory medicines through licensed pharmacies or authorized pharmaceutical suppliers.

Product: R.S. BUDEPRESS LEVO
Composition: Levosalbutamol Hydrochloride (1.25mg) and (0.5mg) Budesonide Inhalation Suspension
Manufacturer/Marketer: Steris Healthcare Pvt. Ltd.
Target Market: India
Dosage Form: Inhalation Suspension
Route: Inhalation via nebuliser
Pack Size: 50 Respules

Availability may depend on current stock and applicable ordering requirements. Always follow the product label and your healthcare professional's instructions.

Conclusion

Levosalbutamol Hydrochloride (1.25mg) and (0.5mg) Budesonide Inhalation Suspension, marketed as R.S. BUDEPRESS LEVO by Steris Healthcare, combines a short-acting bronchodilator with an inhaled corticosteroid to address airway constriction and inflammation through complementary mechanisms.

Levosalbutamol helps relax airway muscles, while budesonide helps control airway inflammation. Correct nebuliser technique, adherence to the prescribed regimen, appropriate mouth rinsing after corticosteroid administration, and regular medical follow-up can support safe and effective treatment.

Do not change the prescribed dose, nebuliser device, or respiratory medicine without professional advice. For sudden or severe breathing difficulty, follow the emergency plan provided by your healthcare professional and seek urgent medical attention when necessary.

Comments

Post a Comment

Popular posts from this blog

Steris Healthcare: Committed to Quality Healthcare and Pharmaceutical Excellence

 Healthcare is one of the most significant sectors influencing the well-being of individuals and communities. As medical science advances, the demand for reliable pharmaceutical products continues to grow. Patients, healthcare professionals, and medical institutions all depend on high-quality medicines that meet strict standards of safety and effectiveness. Pharmaceutical companies play a vital role in ensuring these products are developed, manufactured, and delivered responsibly. Steris Healthcare is committed to supporting better healthcare by providing quality pharmaceutical products designed to improve patient outcomes. Guided by innovation, integrity, and continuous improvement, the company strives to meet the evolving needs of the healthcare industry while maintaining high standards of quality and customer satisfaction. A Vision for Better Healthcare Every successful healthcare organization begins with a clear vision. Steris Healthcare believes that quality medicines and de...
Read more
Megestrol Acetate 160 mg: MAGRAL 160 Uses, Benefits & Safety MAGRAL 160 contains Megestrol Acetate 160 mg and is marketed by Steris Healthcare . Megestrol acetate is a synthetic progestin that is used in specific clinical situations, particularly for managing anorexia, cachexia, or significant unexplained weight loss associated with advanced cancer or AIDS , depending on the approved indication and medical judgment. It is a prescription medicine and should be used under the supervision of a qualified healthcare professional. Megestrol acetate is not a general-purpose appetite booster or routine weight-gain medicine. Before treatment, the underlying reason for poor appetite or weight loss should be evaluated. What is MAGRAL 160 For? MAGRAL 160 may be prescribed when significant appetite loss or involuntary weight loss occurs in certain serious medical conditions. Megestrol acetate can help increase appetite and may contribute to weight gain in appropriately selected patients. Th...
Read more

N-Acetyl L-Cysteine (NAC), Pine Bark Extract and Resveratrol Tablets for Daily Wellness

Image
  N-Acetyl L-Cysteine (NAC), Pine Bark Extract & Resveratrol Tablets: Ingredients and Health Benefits Today’s lifestyle in India has changed a lot. Long working hours, stress, pollution, processed food, and lack of physical activity are affecting overall health. Many people feel tired, low on energy, or struggle with metabolic and hormonal balance tablet . One of the main reasons behind this is oxidative stress. Oxidative stress happens when harmful molecules called free radicals damage the body’s cells. Over time, this may affect immunity, liver health, heart health, skin, and overall wellness.  STYLECYSTIN ENDO is a specially designed antioxidant tablet that contains N-Acetyl L-Cysteine (NAC), Pine Bark Extract, and Resveratrol . This powerful combination supports cellular protection, improves antioxidant levels, and promotes better internal balance. It is commonly recommended as supportive therapy in metabolic conditions, women’s health concerns, and lifestyle-related ...
Read more